Price
Target price
-
-
-
-
-
-
WKN: A2DR4A / Symbol: ARNA / Name: Arena Pharma / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Arena Pharmaceuticals Inc Stock
Our community identified positive and negative aspects for Arena Pharmaceuticals Inc stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Arena Pharmaceuticals Inc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Arena Pharmaceuticals, Inc. (Symbol ARNA) is a biopharmaceutical company based in San Diego, California that focuses on the research, development, and commercialization of novel medications. The company's primary focus is on developing small molecule drugs that target G protein-coupled receptors, which are involved in a wide range of physiological processes. Arena has a diverse pipeline of potential drug candidates in various stages of development, including treatments for pulmonary arterial hypertension, pain, autoimmune diseases, and more. The company's stock is listed on the NASDAQ exchange and is widely considered to be a high-risk/high-reward investment.
Pros and Cons of Arena Pharmaceuticals Inc in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
G***** c******* t* c**********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Arena Pharmaceuticals Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Arena Pharmaceuticals Inc | - | - | - | - | - | - | - |
| Novocure Ltd | 3.070% | 4.053% | -2.114% | -79.652% | -17.268% | -93.443% | - |
| Sage Therapeutics Inc. | -0.350% | 2.037% | -26.156% | -70.428% | -36.125% | -80.292% | - |
| Iovance Biotherapeutics Inc. | -1.440% | 2.211% | -16.359% | 119.362% | 39.152% | -60.289% | - |